AAAAAA

   
Results: 1-16 |
Results: 16
CANARYPOX VIRUS-BASED VACCINES - PRIME-BOOST STRATEGIES TO INDUCE CELL-MEDIATED AND HUMORAL IMMUNITY AGAINST HIV
Authors: TARTAGLIA J EXCLER JL ELHABIB R LIMBACH K MEIGNIER B PLOTKIN S KLEIN M
Citation: J. Tartaglia et al., CANARYPOX VIRUS-BASED VACCINES - PRIME-BOOST STRATEGIES TO INDUCE CELL-MEDIATED AND HUMORAL IMMUNITY AGAINST HIV, AIDS research and human retroviruses, 14, 1998, pp. 291-298
FINE SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN CHIMPANZEES BY HIV CANDIDATE VACCINES
Authors: COEFFIER E GIRARD M BARRESINOUSSI F MEIGNIER B MUCHMORE E FULTZ PN LECLERC C
Citation: E. Coeffier et al., FINE SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN CHIMPANZEES BY HIV CANDIDATE VACCINES, AIDS research and human retroviruses, 14(12), 1998, pp. 1023-1034
RESTRICTED SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN HUMANS BY HIVCANDIDATE VACCINES
Authors: COEFFIER E EXCLER JL KIENY MP MEIGNIER B MOSTE C TARTAGLIA J PIALOUX G SALMONCERON D LECLERC C
Citation: E. Coeffier et al., RESTRICTED SPECIFICITY OF ANTI-V3 ANTIBODIES INDUCED IN HUMANS BY HIVCANDIDATE VACCINES, AIDS research and human retroviruses, 13(17), 1997, pp. 1471-1485
CHALLENGE OF CHIMPANZEES IMMUNIZED WITH A RECOMBINANT CANARYPOX-HIV-1VIRUS
Authors: GIRARD M VANDERRYST E BARRESINOUSSI F NARA P TARTAGLIA J PAOLETTI E BLONDEAU C JENNINGS M VERRIER F MEIGNIER B FULTZ PN
Citation: M. Girard et al., CHALLENGE OF CHIMPANZEES IMMUNIZED WITH A RECOMBINANT CANARYPOX-HIV-1VIRUS, Virology, 232(1), 1997, pp. 98-104
ANTIPLATELET ANTIBODIES DURING THE COURSE OF HIV-PREVENTIVE VACCINE TRIAL
Authors: KAPLAN C MORELKOPP MC KIENY MP KOLBE H SALMON D SICARD D PIALOUX G MEIGNIER B EXCLER JL PLOTKIN S
Citation: C. Kaplan et al., ANTIPLATELET ANTIBODIES DURING THE COURSE OF HIV-PREVENTIVE VACCINE TRIAL, AIDS, 10(4), 1996, pp. 447-449
HUMAN SAFETY AND IMMUNOGENICITY OF A CANARYPOX-RABIES GLYCOPROTEIN RECOMBINANT VACCINE - AN ALTERNATIVE POXVIRUS VECTOR SYSTEM
Authors: FRIES LF TARTAGLIA J TAYLOR J KAUFFMAN EK MEIGNIER B PAOLETTI E PLOTKIN S
Citation: Lf. Fries et al., HUMAN SAFETY AND IMMUNOGENICITY OF A CANARYPOX-RABIES GLYCOPROTEIN RECOMBINANT VACCINE - AN ALTERNATIVE POXVIRUS VECTOR SYSTEM, Vaccine, 14(5), 1996, pp. 428-434
AFRICAN-GREEN MONKEY KIDNEY (VERO) CELLS PROVIDE AN ALTERNATIVE HOST-CELL SYSTEM FOR INFLUENZA-A AND INFLUENZA-B VIRUSES
Authors: GOVORKOVA EA MURTI G MEIGNIER B DETAISNE C WEBSTER RG
Citation: Ea. Govorkova et al., AFRICAN-GREEN MONKEY KIDNEY (VERO) CELLS PROVIDE AN ALTERNATIVE HOST-CELL SYSTEM FOR INFLUENZA-A AND INFLUENZA-B VIRUSES, Journal of virology, 70(8), 1996, pp. 5519-5524
FAILURE OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) SUBTYPE B-DERIVED VACCINE TO PREVENT INFECTION OF CHIMPANZEES BY AN HIV-1 SUBTYPE-E STRAIN
Authors: GIRARD M YUE L BARRESINOUSSI F VANDERRYST E MEIGNIER B MUCHMORE E FULTZ PN
Citation: M. Girard et al., FAILURE OF A HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) SUBTYPE B-DERIVED VACCINE TO PREVENT INFECTION OF CHIMPANZEES BY AN HIV-1 SUBTYPE-E STRAIN, Journal of virology, 70(11), 1996, pp. 8229-8233
A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/
Authors: PIALOUX G EXCLER JL RIVIERE Y GONZALEZCANALI G FEUILLIE V COULAUD P GLUCKMAN JC MATTHEWS TJ MEIGNIER B KIENY MP GONNET P DIAZ I MERIC C PAOLETTI E TARTAGLIA J SALOMON H PLOTKIN S
Citation: G. Pialoux et al., A PRIME-BOOST APPROACH TO HIV PREVENTIVE VACCINE USING A RECOMBINANT CANARYPOX VIRUS EXPRESSING GLYCOPROTEIN-160 (MN) FOLLOWED BY A RECOMBINANT GLYCOPROTEIN-160 (MN LAI)/, AIDS research and human retroviruses, 11(3), 1995, pp. 373-381
SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS
Authors: SALMONCERON D EXCLER JL SICARD D BLANCHE P FINKIELSTZJEN L GLUCKMAN JC AUTRAN B MATTHEWS TJ MEIGNIER B KIENY MP VALENTIN C GONNET P DIAZ I SALOMON H PIALOUX G GONZALEZCANALI G PLOTKIN S
Citation: D. Salmonceron et al., SAFETY AND IMMUNOGENICITY OF A RECOMBINANT HIV TYPE-1 GLYCOPROTEIN-160 BOOSTED BY A V3 SYNTHETIC PEPTIDE IN HIV-NEGATIVE VOLUNTEERS, AIDS research and human retroviruses, 11(12), 1995, pp. 1479-1486
SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT CANARYPOX VIRUS-VACCINE EXPRESSING GP120 GAG/PROTEASE BOOSTED BY A P24E-V3/
Authors: EXCLER JL SALMON D SICARD D AUTRAN B GLUCKMAN JC MATTHEWS TJ MOOG C MEIGNIER B PAOLETTI E TARTAGLIA J KLEIN G CHONG P PLOTKIN S
Citation: Jl. Excler et al., SAFETY AND IMMUNOGENICITY OF A LIVE RECOMBINANT CANARYPOX VIRUS-VACCINE EXPRESSING GP120 GAG/PROTEASE BOOSTED BY A P24E-V3/, AIDS research and human retroviruses, 11, 1995, pp. 138-138
BIOLOGICAL AND IMMUNOGENIC PROPERTIES OF A CANARYPOX-RABIES RECOMBINANT, ALVAC RG (VCP65) IN NON-AVIAN SPECIES
Authors: TAYLOR J MEIGNIER B TARTAGLIA J LANGUET B VANDERHOEVEN J FRANCHINI G TRIMARCHI C PAOLETTI E
Citation: J. Taylor et al., BIOLOGICAL AND IMMUNOGENIC PROPERTIES OF A CANARYPOX-RABIES RECOMBINANT, ALVAC RG (VCP65) IN NON-AVIAN SPECIES, Vaccine, 13(6), 1995, pp. 539-549
VACCINE-INDUCED PROTECTION OF CHIMPANZEES AGAINST INFECTION BY A HETEROLOGOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
Authors: GIRARD M MEIGNIER B BARRESINOUSSI F KIENY MP MATTHEWS T MUCHMORE E NARA PL WEI Q RIMSKY L WEINHOLD K FULTZ PN
Citation: M. Girard et al., VACCINE-INDUCED PROTECTION OF CHIMPANZEES AGAINST INFECTION BY A HETEROLOGOUS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1, Journal of virology, 69(10), 1995, pp. 6239-6248
REPLICATION OF INFLUENZA-A VIRUSES IN A GREEN MONKEY KIDNEY CONTINUOUS CELL-LINE (VERO)
Authors: GOVORKOVA EA KAVERIN NV GUBAREVA LV MEIGNIER B WEBSTER RG
Citation: Ea. Govorkova et al., REPLICATION OF INFLUENZA-A VIRUSES IN A GREEN MONKEY KIDNEY CONTINUOUS CELL-LINE (VERO), The Journal of infectious diseases, 172(1), 1995, pp. 250-253
HIV VACCINES IN CLINICAL-TRIALS - A RECOMBINANT CANARYPOX VIRUS, A CHIMERIC RGP160 AND A SYNTHETIC PEPTIDE IN PRIME BOOST COMBINATIONS/
Authors: MEIGNIER B PIALOUX G SALMON D SICARD D PLOTKIN S
Citation: B. Meignier et al., HIV VACCINES IN CLINICAL-TRIALS - A RECOMBINANT CANARYPOX VIRUS, A CHIMERIC RGP160 AND A SYNTHETIC PEPTIDE IN PRIME BOOST COMBINATIONS/, AIDS research and human retroviruses, 10, 1994, pp. 190000049-190000049
EARLY REGION 3-REPLACEMENT ADENOVIRUS RECOMBINANTS ARE LESS PATHOGENIC IN COTTON RATS AND MICE THAN EARLY REGION 3-DELETED VIRUSES
Authors: BERENCSI K URI A VALYINAGY T VALYINAGY I MEIGNIER B PERETZ FV RANDO RF PLOTKIN SA GONCZOL E
Citation: K. Berencsi et al., EARLY REGION 3-REPLACEMENT ADENOVIRUS RECOMBINANTS ARE LESS PATHOGENIC IN COTTON RATS AND MICE THAN EARLY REGION 3-DELETED VIRUSES, Laboratory investigation, 71(3), 1994, pp. 350-358
Risultati: 1-16 |